Fig. 4

KIRC tumor staging subgroup analysis: Prognostic analysis within localized kidney tumors (A, stage I, II) and advanced/metastatic kidney tumors (B, stage III, IV); (C) risk combined tumor staging prognostic analysis; (D,E)subgroup survival time prediction ROC curve.